Clinical Trials Using Fenretinide

Clinical trials are research studies that involve people. The clinical trials on this list are studying Fenretinide. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-2 of 2
  • Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed / Refractory Peripheral T-cell Lymphomas

    This study addresses the hypothesis that intermittent treatment with fenretinide intravenous emulsion will induce objective responses in patients with relapsed or refractory Peripheral T-cell Lymphoma (PTCL) who have failed at least one prior systemic therapy and will result in acceptable toxicities.
    Location: 4 locations

  • Fenretinide and Safingol in Treating Patients With Relapsed Malignancies

    The purpose of this study is to find out what effects (good and bad) an investigational drug, called safingol, has when it is combined with another investigational drug, called fenretinide, in patients with malignant solid tumors or non-Hodgkin lymphoma. The purpose of this study is also to see what the side effects of safingol and fenretinide are when given by vein to research participants. Researchers also want to find out the highest amount of safingol that can be given by vein when given with a specific dose of fenretinide.
    Location: 3 locations